Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
Panera’s Charged Lemonade
Following lawsuit, chain adds more detailed disclosures about caffeine content.
The Power Gauge by Chaikin Analytics
When it comes to the stock market, no one has a crystal ball.
When TINA.org Investigations Collide
These brand collabs are far from fab.
By the Numbers: Greenwashing Class-Action Lawsuits
TINA.org has tracked more than 150 lawsuits alleging greenwashing.
SharkNinja NeverStick Nonstick Cookware: Heated to 30,000 Degrees Fahrenheit
Lawsuit alleges manufacturing temperature claim is a “physical impossibility.”